Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of a Hemp-Based Topical Cannabinoid Product
NCT07603518Phase 1Recruiting
- Sponsor
- Johns Hopkins University
- Start
- May 2026
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Zygel and dronabinol, sponsored by Johns Hopkins University. Primary endpoint: Change in concentration of oral fluid cannabinoids at Day 14. Started May 2026; status: recruiting.
02
Drugs
Zygeldronabinol
Beyond the preview
Go deeper on NCT07603518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07603518.